Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vidaza in matched unrelated stem cell transplantation
NCT01747499Phase 2Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Apr 2013
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azacitidine in graft-versus-host disease (GVHD), sponsored by Washington University School of Medicine. Started Apr 2013; status: terminated.
02
Drugs
azacitidine
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT01747499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01747499.